Hold These Truths with Dan Crenshaw
A Psychedelic Breakthrough In the Treatment of Trauma and Addiction | Dr. Nolan Williams
Apr 26, 2024
Dr. Nolan Williams discusses a clinical trial using ibogaine to treat veterans with PTSD and addiction, achieving an 83% remission rate. They explore the unique effects of ibogaine compared to classic psychedelics, the potential for combating addiction, and the therapeutic journey individuals undergo with ibogaine treatment.
24:25
Episode guests
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Ibogaine treatment showed 83% remission rate for PTSD, addiction; different from classic psychedelics in brain impact.
- Veterans reported habit reversal, cognition improvement with Ibogaine treatment, suggesting potential in addiction intervention.
Deep dives
Study on Ibogaine's Effects on War-Related Symptoms
A study conducted around veterans traveling to Mexico to use Ibogaine as a treatment for war wounds like TBI, PTSD, depression, and anxiety showed significant results. The trial included MRI brain scans, EEGs, and neurocognitive testing, revealing that most participants returned with reduced or resolved symptoms. Notably, the therapy reversed traumatic brain injury disability, a unique observation from a drug's impact. The findings suggest a lasting and profound effect, urging further research and support for Ibogaine treatment.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
